Prelude Therapeutics (PRLD) Payables (2019 - 2026)
Prelude Therapeutics' Payables was $2.03 million in Q2 2026, down 59.0% from $4.96 million a year earlier and down 1.8% from the prior quarter.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Payables (2019 - 2026) Analysis & Trends
At the end of FY2025, Payables at Prelude Therapeutics came in at $3.98 million, down 48.5% from FY2024.
- Payables shows a five-year compound annual growth rate of 0.3% (FY2020 to FY2025).
- In earlier years, Payables was $7.73 million in FY2024 (+68.8%), $4.58 million in FY2023 (-32.4%), $6.78 million in FY2022 (-13.6%) and $7.84 million in FY2021 (+100.0%).
- The Q2 2026 figure marks the lowest quarterly Payables since Q4 2019.
- Compared with a year earlier, Payables has declined for five straight quarters, with an average decline of 19.5% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q3 2021 (growth of 118.0%); the worst was Q1 2026 (a decline of 64.5%).
- Per Business Quant data, PRLD's Payables in the three quarters before Q2 2026 was $2.07 million (Q1 2026), $3.98 million (Q4 2025) and $2.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Prelude Therapeutics | 312.03 Mn | -285.27 Mn | - | 2.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.03 Mn |
| Mar 31, 2026 | 2.07 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 4.96 Mn |
| Mar 31, 2025 | 5.83 Mn |
| Dec 31, 2024 | 7.73 Mn |
| Sep 30, 2024 | 5.92 Mn |
| Jun 30, 2024 | 6.17 Mn |
| Mar 31, 2024 | 5.31 Mn |
| Dec 31, 2023 | 4.58 Mn |
| Sep 30, 2023 | 5.17 Mn |
| Jun 30, 2023 | 5.59 Mn |
| Mar 31, 2023 | 7.08 Mn |
| Dec 31, 2022 | 6.78 Mn |
| Sep 30, 2022 | 10.25 Mn |
| Jun 30, 2022 | 6.27 Mn |
| Mar 31, 2022 | 7.39 Mn |
| Dec 31, 2021 | 7.84 Mn |
| Sep 30, 2021 | 11.06 Mn |
API Access
Prelude Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();